Research ExplorerScientific StaffSaid Chosro Farschtschi Publications

Said Chosro Farschtschi

graph of relations
Affiliations
1 - 50 out of 51Page size: 50
Sort by: Type

Publications

  1. Conference contribution - Article for conference › Research › Peer-reviewed

  2. Platelet mediated arteriogenesis: involvement of GPIb alpha and GPIIb receptors

    Pagel, J-I., von Bruehl, M-L., Chandraratne, S., Farschtschi, S. C., Schaper, W., Massberg, S. & Deindl, E., 2011, Journal of Vascular Research . Vol. Volume: 48.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Article for conference › Research › peer-review

  3. Conference contribution - Poster › Research

  4. Charakteristische Mikroläsionen bei Schwannomatose?

    Farschtschi, S. C., Bäumer, P., Pham, M., Bäumer, T. & Mautner, V-F., 09.2012, 85. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie, CC Hamburg.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  5. Comparability of 1.5T and 3.0T MRI-Volumetrics in Neurofibromatosis Type 1

    Farschtschi, S. C., Dombi, E., Widemann, B., Fünsterer, C. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  6. Faszikuläre Mikroläsionen und Neuropathie bei der Schwannomatose

    Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G., Pham, M. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  7. Multiple Parameter der Nervenerregbarkeit bei der NF2

    Peter, G., Farschtschi, S. C., Bostock, H. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  8. Muskelaktionspotenzial-Scan und Ultraschall zur Erfassung der Neuropathie bei der Neurofibromatose Typ 2

    Farschtschi, S. C., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V-F., 19.11.2016, 20. Tagung der Arbeitsgemeinschaft Neurofibromatose.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  9. Neuropathischer Schmerz ohne Neuropathie bei der Schwannomatose

    Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G. & Mautner, V-F., 2014, 87. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  10. Response Of Spinal Ependymomas In Neurofibromatosis Type 2 to Bevacizumab - A Case Series

    Farschtschi, S. C., David, W., Blakeley, J. O., Merker, V. L., Plotkin, S. R., Schuhmann, M. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.

    Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research

  11. SCORING: Contribution to collected editions/anthologies › Education › Not peer-reviewed

  12. Schwannomatose

    Mautner, V-F. & Farschtschi, S. C., 2016, Ratgeber Schwannomatose: Schwannomatose. 1 ed. Hamburg: Bundesverband Neurofibromatose e.V., 27 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  13. SCORING: Contribution to collected editions/anthologies › Education › Peer-reviewed

  14. Therapie und Verlauf neurologischer Erkrankungen: Kapitel H7: Neurokutane Syndrome

    Farschtschi, S. C., Tatagiba, M. & Mautner, V-F., 2017, Therapie und Verlauf neurologischer Erkrankungen. Diener, H-C., Gerloff, C. & Dieterich, M. (eds.). 7 ed. Stuttgart: Kohlhammer, p. 997 - 1006 10 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

  15. SCORING: Journal article › Research › Peer-reviewed

  16. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden

    Özden, C., Mautner, V-F., Farschtschi, S., Molwitz, I., Ristow, I., Bannas, P., Well, L., Klutmann, S., Adam, G., Apostolova, I. & Buchert, R., 2024, In: J NEUROIMAGING. 34, 1, p. 138-144 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Atypical Neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities

    Kresbach, C., Dottermusch, M., Eckhardt, A., Ristow, I., Paplomatas, P., Altendorf, L., Wefers, A. K., Bockmayr, M., Belakhoua, S., Tran, I., Pohl, L., Neyazi, S., Bode, H., Farschtschi, S., Well, L., Friedrich, R. E., Reuss, D., Snuderl, M., Hagel, C., Mautner, V-F. & Schüller, U., 05.09.2023, In: NEURO-ONCOLOGY. 25, 9, p. 1644-1655 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Farschtschi, S., Merker, V. L., Wolf, D., Schuhmann, M., Blakeley, J., Plotkin, S. R., Hagel, C. & Mautner, V. F., 06.2016, In: ACTA NEUROL SCAND. 133, 6, p. 475-480

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis

    Farschtschi, S. C., Mainka, T., Glatzel, M., Hannekum, A-L., Hauck, M., Gelderblom, M., Hagel, C., Friedrich, R. E., Schuhmann, M. U., Schulz, A., Morrison, H., Kehrer-Sawatzki, H., Luhmann, J., Gerloff, C., Bendszus, M., Bäumer, P. & Mautner, V-F., 18.05.2020, In: INT J MOL SCI. 21, 10

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Clinical characterization of children and adolescents with NF1 microdeletions

    Kehrer-Sawatzki, H., Kluwe, L., Salamon, J., Well, L., Farschtschi, S., Rosenbaum, T. & Mautner, V-F., 10.2020, In: CHILD NERV SYST. 36, 10, p. 2297-2310 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Critical Role of Platelet Glycoprotein Ibα in Arterial Remodeling

    Chandraratne, S., von Bruehl, M-L., Pagel, J-I., Stark, K., Kleinert, E., Konrad, I., Farschtschi, S., Coletti, R., Gärtner, F., Chillo, O., Legate, K. R., Lorenz, M., Rutkowski, S., Caballero-Martinez, A., Starke, R., Tirniceriu, A., Pauleikhoff, L., Fischer, S., Assmann, G., Mueller-Hoecker, J., Ware, J., Nieswandt, B., Schaper, W., Schulz, C., Deindl, E. & Massberg, S., 2015, In: ARTERIOSCL THROM VAS. 35, 3, p. 589-597

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis

    Ahlawat, S., Fayad, L. M., Khan, M. S., Bredella, M. A., Harris, G. J., Evans, D. G., Farschtschi, S., Jacobs, M. A., Chhabra, A., Salamon, J. M., Wenzel, R., Mautner, V. F., Dombi, E., Cai, W., Plotkin, S. R., Blakeley, J. O. & Whole Body MRI Committee for the REiNS International Collaboration, 16.08.2016, In: NEUROLOGY. 87, 7 Suppl 1, p. S31-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging

    Well, L., Salamon, J. M., Kaul, M. G., Farschtschi, S., Herrmann, J., Geier, K. I., Hagel, C., Bockhorn, M., Bannas, P., Adam, G., Mautner, V. F. & Derlin, T., 18.03.2019, In: NEURO-ONCOLOGY. 21, 4, p. 508-516 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis

    Farschtschi, S. C., Kluwe, L., Schön, G., Friedrich, R. E., Matschke, J., Glatzel, M., Hagel, C. & Mautner, V-F., 03.2020, In: BRAIN PATHOL. 30, 2, p. 386-391 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2

    Godel, T., Mautner, V-F., Farschtschi, S., Pham, M., Schwarz, D., Kronlage, M., Gugel, I., Heiland, S., Bendszus, M. & Bäumer, P., 04.2018, In: ANN NEUROL. 83, 4, p. 854-857 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Early-onset stroke in two siblings with Neurofibromatosis type 1

    Rukavina, K., Töpper, R., Kunze, A., Hess, A., Glatzel, M., Valdueza, J. M., Farschtschi, S. & Hagel, C., 10.2019, In: EUR J MED GENET. 62, 10, p. 103710

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

    Farschtschi, S., Park, S-J., Sawitzki, B., Oh, S-J., Kluwe, L., Mautner, V. F. & Kurtz, A., 09.2016, In: CANCER IMMUNOL IMMUN. 65, 9, p. 1113-1121

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1

    Ristow, I., Madesta, F., Well, L., Shenas, F. Y., Wright, F., Molwitz, I., Farschtschi, S., Bannas, P., Adam, G., Mautner, V. F., Werner, R. & Salamon, J., 03.10.2022, In: NEURO-ONCOLOGY. 24, 10, p. 1790-1798 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth

    Well, L., Döbel, K., Kluwe, L., Bannas, P., Farschtschi, S., Adam, G., Mautner, V-F. & Salamon, J., 05.2021, In: PLOS GENET. 17, 5, p. e1009517

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Growth in neurofibromatosis 1 microdeletion patients

    Ning, X., Farschtschi, S., Jones, A., Kehrer-Sawatzki, H., Mautner, V-F. & Friedman, J. M., 26.06.2015, In: CLIN GENET. 89, 3, p. 351-354

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation

    Farschtschi, S., Mautner, V-F., Hollants, S., Hagel, C., Spaepen, M., Schulte, C., Legius, E. & Brems, H., 01.01.2015, In: BMC MED GENET. 16, 1, p. 6

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis Type 2

    Godel, T., Bäumer, P., Farschtschi, S., Püschel, K., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M., Hagel, C. & Mautner, V-F., 03.2022, In: CLIN NEURORADIOL. 32, 1, p. 277-285 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases

    Kluwe, L., Scholze, C., Schmidberg, L. M., Wichmann, J. L., Gemkov, M., Keller, M. J. & Farschtschi, S. C., 2023, In: Medical cannabis and cannabinoids. 6, 1, p. 89-96 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools

    Kollmann, P., Mautner, V-F., Koeppen, J., Wenzel, R., Friedman, J. M., Salamon, J. & Farschtschi, S., 14.07.2020, In: SCI REP-UK. 10, 1, p. 11541

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Multifocal Nerve Lesions and LZTR1 Germline Mutations in Segmental Schwannomatosis

    Farschtschi, S., Mautner, V-F., Pham, M., Nguyen, R., Kehrer-Sawatzki, H., Hutter, S., Friedrich, R. E., Schulz, A., Morrison, H., Jones, D. T. W., Bendszus, M. & Bäumer, P., 10.2016, In: ANN NEUROL. 80, 4, p. 625-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2

    Farschtschi, S., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V. F., 03.2017, In: MUSCLE NERVE. 55, 3, p. 350-358

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Non-optic glioma in adults and children with neurofibromatosis 1

    Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Friedman, J. M. & Mautner, V-F., 15.02.2017, In: ORPHANET J RARE DIS. 12, 1, p. 34

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Null phenotype of neurofibromatosis type 1 in a carrier of a heterozygous atypical NF1 deletion due to mosaicism

    Kluwe, L., Friedrich, R. E., Farschtschi, S. C., Hagel, C., Kehrer-Sawatzki, H. & Mautner, V-F., 07.2020, In: HUM MUTAT. 41, 7, p. 1226-1231 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Peripheral nervous system alterations in infant and adult neurofibromatosis type 2

    Godel, T., Bäumer, P., Farschtschi, S., Gugel, I., Kronlage, M., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M. & Mautner, V-F., 06.08.2019, In: NEUROLOGY. 93, 6, p. e590-e598

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas

    Kehrer-Sawatzki, H., Kluwe, L., Friedrich, R. E., Summerer, A., Schäfer, E., Wahlländer, U., Matthies, C., Gugel, I., Farschtschi, S., Hagel, C., Cooper, D. N. & Mautner, V-F., 07.2018, In: HUM GENET. 137, 6-7, p. 543-552 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1

    Jett, K., Nguyen, R., Arman, D., Birch, P., Chohan, H., Farschtschi, S., Fuensterer, C., Kluwe, L., Friedman, J. M. & Mautner, V. F., 07.2015, In: AM J MED GENET A. 167, 7, p. 1518-24 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues

    Rauen, K. A., Huson, S. M., Burkitt-Wright, E., Evans, D. G., Farschtschi, S., Ferner, R. E., Gutmann, D. H., Hanemann, C. O., Kerr, B., Legius, E., Parada, L. F., Patton, M., Peltonen, J., Ratner, N., Riccardi, V. M., van der Vaart, T., Vikkula, M., Viskochil, D. H., Zenker, M. & Upadhyaya, M., 2015, In: AM J MED GENET A. 167A, 1, p. 1-10

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2

    Farschtschi, S., Kollmann, P., Dalchow, C., Stein, A. & Mautner, V-F., 12.2015, In: EUR ARCH OTO-RHINO-L. 272, 12, p. 3857-60 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1

    Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Mautner, V-F. & Friedman, J. M., 23.04.2018, In: ORPHANET J RARE DIS. 13, p. 62

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Spatial Distribution and Long-Term Alterations of Peripheral Nerve Lesions in Schwannomatosis

    Godel, T., Bäumer, P., Farschtschi, S., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M. & Mautner, V-F., 23.03.2022, In: DIAGNOSTICS. 12, 4, 780.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1

    Well, L., Jaeger, A., Kehrer-Sawatzki, H., Farschtschi, S., Avanesov, M., Sauer, M., de Sousa, M. T., Bannas, P., Derlin, T., Adam, G., Mautner, V. F. & Salamon, J. M., 2020, In: PLOS ONE. 15, 4, p. e0232031

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis

    Kehrer-Sawatzki, H., Farschtschi, S., Mautner, V-F. & Cooper, D. N., 02.2017, In: HUM GENET. 136, 2, p. 129-148

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target

    Farschtschi, S., Kluwe, L., Park, S-J., Oh, S-J., Mah, N., Mautner, V-F. & Kurtz, A., 07.2020, In: CANCER IMMUNOL IMMUN. 69, 7, p. 1307-1313 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Other (editorial matter etc.) › Research

  50. Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI

    Well, L., Careddu, A., Stark, M., Farschtschi, S., Bannas, P., Adam, G., Mautner, V-F. & Salamon, J., 30.08.2021, In: SCI REP-UK. 11, 1, p. 17669

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  51. In Reply Letter to the Editor The Neurofibromatoses by Dr. med. Said Farschtschi, Prof. Dr. med. Victor-Felix Mautner, Dr. med. Anna Cecilia Lawson McLean, Dr. med. Dr. rer. nat. Alexander Schulz, Prof. Dr. med. Dr. med. dent. Reinhard E. Friedrich, Prof. Dr. med. Steffen K. Rosahl in issue 20/2020

    Farschtschi, S., 29.01.2021, In: DTSCH ARZTEBL INT. 118, 4, p. 56

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  52. Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants

    Hutter, S., Piro, R. M., Reuss, D. E., Hovestadt, V., Sahm, F., Farschtschi, S., Kehrer-Sawatzki, H., Wolf, S., Lichter, P., von Deimling, A., Schuhmann, M. U., Pfister, S. M., Jones, D. T. W. & Mautner, V. F., 01.09.2014, In: ACTA NEUROPATHOL. 128, 3, p. 449-52 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  53. SCORING: Review article › Research

  54. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

    Carton, C., Evans, D. G., Blanco, I., Friedrich, R. E., Ferner, R. E., Farschtschi, S., Salvador, H., Azizi, A. A., Mautner, V., Röhl, C., Peltonen, S., Stivaros, S., Legius, E., Oostenbrink, R. & ERN GENTURIS NF1 Tumour Management Guideline Group, 02.2023, In: ECLINICALMEDICINE. 56, 101818.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  55. Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities

    Schulz, A., Grafe, P., Hagel, C., Bäumer, P., Morrison, H., Mautner, V-F. & Farschtschi, S., 01.01.2018, In: EXP NEUROL. 299, Pt B, p. 334-344 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  56. Revidierte Diagnosekriterien für die Neurofibromatose Typ 1 (NF1) ermöglichen eine frühe präzise differenzialdiagnostische Abgrenzung zu anderen RASopathien und erleichtern die Diagnose

    Kehrer-Sawatzki, H., Farschtschi, S. C. & Mautner, V-F., 30.09.2021, In: MONATSSCHR KINDERH.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  57. The Neurofibromatoses

    Farschtschi, S., Mautner, V-F., McLean, A. C. L., Schulz, A., Friedrich, R. & Rosahl, S. K., 15.05.2020, In: DTSCH ARZTEBL INT. 117, 20, p. 354-360 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Previous 1 2 Next